Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
929.35
-7.00 (-0.75%) Zydus Lifesciences - Quaterly Results
Date: 12-08-2025
The Sales for the quarter ended June 2025 of Rs. 25883.00 million declined by -37.78% from Rs. 41602.00 millions.Net Profit for the quarter ended June 2025 dipped to Rs. 3847.00 millions from Rs. 17008.00 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 7425.00 millions from 24795.00 millions in the corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202506 | 202406 | % Var | 202506 | 202406 | % Var | 202503 | 202403 | % Var | |
| Sales | 25883.00 | 41602.00 | -37.78 | 25883.00 | 41602.00 | -37.78 | 151163.00 | 108187.00 | 39.72 |
| Other Income | 1571.00 | 1066.00 | 47.37 | 1571.00 | 1066.00 | 47.37 | 9058.00 | 11595.00 | -21.88 |
| PBIDT | 7425.00 | 24795.00 | -70.05 | 7425.00 | 24795.00 | -70.05 | 84325.00 | 51435.00 | 63.94 |
| Interest | 1376.00 | 1154.00 | 19.24 | 1376.00 | 1154.00 | 19.24 | 4639.00 | 3907.00 | 18.74 |
| PBDT | 6049.00 | 23641.00 | -74.41 | 6049.00 | 23641.00 | -74.41 | 79686.00 | 47442.00 | 67.97 |
| Depreciation | 1300.00 | 1306.00 | -0.46 | 1300.00 | 1306.00 | -0.46 | 5239.00 | 5044.00 | 3.87 |
| PBT | 4749.00 | 22335.00 | -78.74 | 4749.00 | 22335.00 | -78.74 | 74447.00 | 42398.00 | 75.59 |
| TAX | 902.00 | 5327.00 | -83.07 | 902.00 | 5327.00 | -83.07 | 16698.00 | 7983.00 | 109.17 |
| Deferred Tax | 6.00 | 11.00 | -45.45 | 6.00 | 11.00 | -45.45 | 873.00 | -1360.00 | -164.19 |
| PAT | 3847.00 | 17008.00 | -77.38 | 3847.00 | 17008.00 | -77.38 | 57749.00 | 34415.00 | 67.80 |
| Equity | 1006.00 | 1006.00 | 0.00 | 1006.00 | 1006.00 | 0.00 | 1006.00 | 1006.00 | 0.00 |
| PBIDTM(%) | 28.69 | 59.60 | -51.87 | 28.69 | 59.60 | -51.87 | 55.78 | 47.54 | 17.33 |